Home Cart Sign in  
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 13010-47-4 Chemical Structure| 13010-47-4

Structure of Lomustine
CAS No.: 13010-47-4

Chemical Structure| 13010-47-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Lomustine is an alkylating nitrosourea compound used in chemotherapy. Lomustine (420 μM) triggers apoptosis through the mitochondrial pathway via decrease in the level of the anti-apoptosis proteins Bcl-2 and Bcl-xl, respectively, in both medulloblastoma and normal human epithelial and fibroblast cells. Lomustine induces cell cycle delay in G2/M phase in medulloblastoma cells and up-regulates p21 protein level in a p53-independent manner in HFSN1 cells.

Synonyms: CCNU; NSC 79037; WR139017.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Product Citations

Ingraham, Charles H. IV ; Stalinska, Joanna ; Carson, Sean C. ; Colley, Susan B. ; Rak, Monika ; Lassak, Adam , et al.

Abstract: Glioblastomas are highly aggressive brain tumors for which therapeutic options are very limited. In a quest for new anti-glioblastoma drugs, we focused on specific structural modifications to the benzoyl-phenoxy-acetamide (BPA) structure present in a common lipid-lowering drug, fenofibrate, and in our first prototype glioblastoma drug, PP1. Here, we propose extensive computational analyses to improve the selection of the most effective glioblastoma drug candidates. Initially, over 100 structural BPA variations were analyzed and their physicochemical properties, such as water solubility (- logS), calculated partition coefficient (ClogP), probability for BBB crossing (BBB_SCORE), probability for CNS penetration (CNS-MPO) and calculated cardiotoxicity (hERG), were evaluated. This integrated approach allowed us to select pyridine variants of BPA that show improved BBB penetration, water solubility, and low cardiotoxicity. Herein the top 24 compounds were synthesized and analyzed in cell culture. Six of them demonstrated glioblastoma toxicity with IC50 ranging from 0.59 to 3.24 µM. Importantly, one of the compounds, HR68, accumulated in the brain tumor tissue at 3.7 ± 0.5 µM, which exceeds its glioblastoma IC50 (1.17 µM) by over threefold.

Alternative Products

Product Details of Lomustine

CAS No. :13010-47-4
Formula : C9H16ClN3O2
M.W : 233.70
SMILES Code : O=C(NC1CCCCC1)N(CCCl)N=O
Synonyms :
CCNU; NSC 79037; WR139017.
MDL No. :MFCD00012392
InChI Key :GQYIWUVLTXOXAJ-UHFFFAOYSA-N
Pubchem ID :3950

Safety of Lomustine

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H301-H360-H371-H340-H350
Precautionary Statements:P501-P260-P270-P202-P201-P264-P280-P308+P311-P301+P310+P330-P405
Class:6.1
UN#:2811
Packing Group:

Related Pathways of Lomustine

DNA

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
LN229 and A172 cells 10 µM 2 days To test the senolytic effect of Lomustine on senescent cells, results showed no significant reduction in senescence levels PMC9406955
B16F10 cells 0, 1.57, 3.13, 6.25, 12.5, 25, 50, 100 μM 24 hours To detect the cytotoxicity of lomustine on B16F10 cells. The experimental results showed that lomustine significantly inhibited the survival rate of B16F10 cells. PMC6028752
MCF-7 2.5, 10, 25, 50, 100, and 200 µM 72 hours To evaluate the cytotoxicity of Lomustine and its complex on MCF-7 cells, the results showed that Lomustine has strong cytotoxicity on MCF-7 cells with an IC50 of 8.41 μM. PMC11574061
HT-29 2.5, 10, 25, 50, 100, and 200 µM 72 hours To evaluate the cytotoxicity of Lomustine and its complex on HT-29 cells, the results showed that Lomustine has strong cytotoxicity on HT-29 cells with an IC50 of 8.91 μM. PMC11574061
MCF-10A 2.5, 10, 25, 50, 100, and 200 µM 72 hours To evaluate the cytotoxicity of Lomustine and its complex on MCF-10A cells, the results showed that Lomustine has cytotoxicity on MCF-10A cells with an IC50 of 48.9 μM. PMC11574061
CCD-18Co 2.5, 10, 25, 50, 100, and 200 µM 72 hours To evaluate the cytotoxicity of Lomustine and its complex on CCD-18Co cells, the results showed that Lomustine has cytotoxicity on CCD-18Co cells with an IC50 of 56.2 μM. PMC11574061

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
C57BL/6 mice B16F10 cell xenograft model Intraperitoneal injection 50 mg/kg Every 2 days for 14 days To evaluate the antitumor effect of lomustine on the B16F10 cell xenograft model. The experimental results showed that lomustine significantly inhibited tumor growth and enhanced the antitumor effect of carmustine. PMC6028752

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT02551718 Acute Leukemia of Ambiguous Li... More >>neage Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Myeloid Leukemia Refractory Acute Myeloid Leukemia Refractory Adult Acute Lymphoblastic Leukemia Refractory Childhood Acute Lymphoblastic Leukemia Less << Not Applicable Recruiting - United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Pamela S. Becker    206-616-1589    pbecker@u.washington.edu    Principal Investigator: Pamela S. Becker Less <<
NCT00303810 Brain and Central Nervous Syst... More >>em Tumors Less << Not Applicable Completed - Germany ... More >> University Medical Center Hamburg - Eppendorf Hamburg, Germany, D-20246 Less <<
NCT00278278 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 3 Unknown - United States, Texas ... More >> M. D. Anderson Cancer Center at University of Texas Houston, Texas, United States, 77030-4009 Less <<
NCT00317408 Lymphoma Not Applicable Unknown - -
NCT00003101 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Completed - United States, Alabama ... More >> University of Alabama Comprehensive Cancer Center Birmingham, Alabama, United States, 35294 United States, California Stanford University Medical Center Stanford, California, United States, 94305-5408 United States, Illinois Evanston Northwestern Health Care Evanston, Illinois, United States, 60201 Loyola University Medical Center Maywood, Illinois, United States, 60153 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Canada, Alberta Tom Baker Cancer Center - Calgary Calgary, Alberta, Canada, T2N 4N2 Canada, Ontario Cancer Care Ontario-London Regional Cancer Centre London, Ontario, Canada, N6A 4L6 Less <<
NCT00003788 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 3 Unknown - United States, Colorado ... More >> Rocky Mountain Neurological Associates Englewood, Colorado, United States, 80110 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263-0001 United States, Pennsylvania Western Pennsylvania Hospital Pittsburgh, Pennsylvania, United States, 15224 Canada, Ontario St. Michael's Hospital-Annex Toronto, Ontario, Canada, M5B 1A6 Less <<
NCT01883180 Hematopoietic Stem Cell Transp... More >>lantation Antithymocyte Globulin Viral Infection Less << Phase 4 Completed - China, Guangdong ... More >> Department of Hematology,Nanfang Hospital, Southern Medical University Guangzhou, Guangdong, China, 510515 Less <<
NCT03462095 Precursor Cell Lymphoblastic L... More >>eukemia-Lymphoma Less << Not Applicable Recruiting December 1, 2022 Russian Federation ... More >> National Research Center for Hematology Recruiting Moscow, Russian Federation, 125167 Contact: Elena N Parovichnikova, MD PhD    +7(495)6124313    elenap@blood.ru Less <<
NCT02643589 Hematopoietic Stem Cell Transp... More >>lantation Less << Not Applicable Unknown December 2016 China, Guangdong ... More >> Nanfang Hospital, Southern Medical University Recruiting Guangzhou, Guangdong, China, 510515 Contact: Ren Lin    +86-020-62787883    lansinglinren@hotmail.com Less <<
NCT01954030 Malignant Glioma (WHO Grade II... More >>I or IV) Less << Phase 1 Terminated(Study terminated ea... More >>rly due to funding reasons prior to completing Phase 1) Less << - United States, North Carolina ... More >> The Preston Robert Tisch Brain Tumor Center at Duke Durham, North Carolina, United States, 27710 Less <<
NCT02788201 Urothelial Carcinoma ... More >> Bladder Cancer Urinary Bladder Neoplasms Less << Phase 2 Recruiting July 1, 2020 United States, Maryland ... More >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office    888-624-1937 Less <<
NCT02992548 Chronic Kidney Disease Phase 4 Active, not recruiting August 2018 Korea, Republic of ... More >> Dong-A University Busan, Korea, Republic of, 602715 Inje University, Pusan Paik Hospital Busan, Korea, Republic of Less <<
NCT00058370 Brain and Central Nervous Syst... More >>em Tumors Less << Not Applicable Active, not recruiting February 2019 United States, New York ... More >> Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center New York, New York, United States, 10032 Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00459745 Combined Hyperlipidemia Phase 3 Completed - -
NCT03603795 Acute Myeloid Leukemia Phase 2 Recruiting September 2024 France ... More >> CHU ANGERS - Maladies du sang Not yet recruiting Angers, France, 49933 Contact: Mathilde HUNAULT, Dr    02 41 35 45 82    mahunault@chu-angers.fr    CH de la Côte Basque - Hématologie Not yet recruiting Bayonne, France, 64109 Contact: Anne BANOS, Dr    +33 5 59 44 38 32    abanos@ch-cotebasque.fr    CHU Estaing Not yet recruiting Clermont-Ferrand, France, 63003 Contact: Aurélie RAVINET, Dr    04 73 75 00 65    aravinet@chu-clermontferrand.fr    CHU Grenoble - Hématologie Clinique Recruiting Grenoble, France, 38043 Contact: Claude-Eric BULABOIS, Dr    04 76 76 57 55    cebulabois@chu-grenoble.fr    Institut Paoli-Calmettes - Hématologie 2 Not yet recruiting Marseille, France, 13000 Contact: Norbert VEY, Pr    +33 4 91 22 36 95    veyn@ipc.unicancer.fr    Hôpital Saint-Eloi - Hématologie Clinique Not yet recruiting Montpellier, France, 34295 Contact: Yosr HICHERI, Dr    +33 4 67 33 24 18    y-hicheri@chu-montpellier.fr    HOPITAL E. MULLER - Hématologie Not yet recruiting Mulhouse, France, 68070 Contact: Mario OJEDA-URIBE, Dr    +33(0)3 89 64 77 55    ojeda-uribem@ghrmsa.fr    CHU HOTEL DIEU - Hématologie Clinique Not yet recruiting Nantes, France, 44093 Contact: Pierre PETERLIN, Dr    +33(0)2 40 08 32 71    pierre.peterlin@chu-nantes.fr    CHU Caremeau Not yet recruiting Nîmes, France, 30029 Contact: Eric JOURDAN, Dr    04 66 68 32 31    eric.jourdan@chu-nimes.fr    CHU La Milétrie - Hématologie Clinique Not yet recruiting Poitiers, France, 86000 Contact: Maria-Pilar GALLEGO-HERNANZ, Dr    +33(0)5 49 44 44 44    maria-pilar.gallego-hernanz@chu-poitiers.fr    CHU Pontchaillou Not yet recruiting Rennes, France, 35033 Contact: Marc BERNARD, Dr    02 40 08 32 71    marc.bernard@chu-rennes.fr    CHU Hautepierre - Hématologie Not yet recruiting Strasbourg, France, 67098 Contact: Bruno LIOURE, Dr    +33(0)3 88 12 76 76    bruno.lioure@chru-strasbourg.fr    Institut Universitaire du Cancer de Toulouse Oncopole - Service d'Hématologie Recruiting Toulouse, France, 31059 Contact: Christian RECHER, Pr    +33 5 31 15 63 55    recher.christian@iuct-oncopole.fr    Sponsor FILO Not yet recruiting Tours, France, 37044 Contact: Mélanie COTTOT, Mrs    +33247478899    m.dupin@chu-tours.fr    CHU de Brabois Not yet recruiting Vandœuvre-lès-Nancy, France, 54500 Contact: Caroline BONMATI, Dr    03 83 15 52 49    c.bonmati@chu-nancy.fr Less <<
NCT03632135 Recurrent Glioblastoma Phase 3 Recruiting January 31, 2022 United States, Mississippi ... More >> University of Mississippi Medical Center Recruiting Jackson, Mississippi, United States, 39216 Contact: Mark D. Anderson, MD    601-984-5517    manderson4@umc.edu    United States, Ohio University of Cincinnati Recruiting Cincinnati, Ohio, United States, 45267 Contact: Nicholas Marko, MD    513-558-3559    nicholas.marko@uc.edu    Contact: , RN          Toledo University Recruiting Toledo, Ohio, United States, 43614 Contact: Jason Schroeder, MD    419-383-4000    Jason.Schroeder5@UToledo.edu    Contact: Stephanie Smiddy, RN    419-383-6962    stephanie.smiddy@UToledo.edu    United States, Pennsylvania The Penn State Univeristy College of Medicine Recruiting Hershey, Pennsylvania, United States, 17033 Contact: Dawit Aregawi, MD    717-531-3828    daregawi@PennStateHealth.psu.edu    Allegheny Health Network Recruiting Pittsburgh, Pennsylvania, United States, 15212 Contact: Tulika Ranjan, MD    412-770-3039    Tulika.RANJAN@ahn.org    United States, West Virginia Charleston Area Medical Center Recruiting Charleston, West Virginia, United States, 25326 Contact: Steven Jubelirer, MD    304-388-8380    steven.jubelirer@camc.org    Contact: Tina Garten, RN    304-388-9995    Tina.Garten@camc.org Less <<
NCT00431561 Glioblastoma ... More >>Anaplastic Astrocytoma Less << Phase 2 Completed - Austria ... More >> Universitätsklinik Innsbruck; Abteilung für Neurochirurgie Innsbruck, Austria, 6020 Landes-Nervenklinik Wagner-Jauregg Linz, Austria, 4020 Kaiser Franz Josef Spital, Abteilung für Neurologie Wien, Austria, 1100 Georgia Sarajishvili Institute of Clinical Neurology and Neurosurgery Tbilisi, Georgia, 0114 Germany Medizinische Klinik und Poliklinik mit Schwerpunkt Onkologie und Hämatologie, Charité Campus Mitte Berlin, Germany, 10117 Klinik und Poliklinik für Neurologie Cottbus, Germany, 03048 Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden Dresden, Germany, 01307 Universitätsklinikum Gießen, Neurochirurgische Universitätsklinik Gießen, Germany, 35392 Universitätsklinikum Kiel, Klinik für Neurochirurgie Kiel, Germany, 24106 Universitätsklinikum Leipzig, Klinik und Poliklinik für Neurochirurgie Leipzig, Germany, 04103 Universitätsklinik Magdeburg, Klinik für Neurochirurgie Magdeburg, Germany, 39120 Universitätskliniken Mainz, Neurochirurgische Klinik und Poliklinik Mainz, Germany, 55131 Universitätsklinikum Münster, Klinik und Poliklinik für Neurochirurgie Münster, Germany, 48149 Klinikum und Poliklinik für Neurologie, Universität Regensburg Regensburg, Germany, 93053 Klinikum Saarbrücken, Neurochirurgie Saarbrücken, Germany, 66119 Neurologische Universitätsklinik Tübingen Tübingen, Germany, 72076 India Department of Neurosurgery, Amrita Institute of Medical Sciences & Research Centre Cochin, Kerala, India, 682026 Sree Chitra Tirunal Institute for Medical Sciences & Technology, Department of Neurosurgery Trivandrum, Kerala, India, 695011 Manipal Hospital; Manipal Institute for Neurological Disorders Bangalore, India, 560017 Department of Neurosurgery, National Institute of Mental Health and Neurosciences Bangalore, India, 560029 Department of Medical Oncology, Nizam's Institute of Medical Sciences Hyderabad, India, 500082 Department of Neurosurgery, LTMG Hospital & LTM Medical College Mumbai, India, 400022 Department of Neurosurgery, Neurosciences Center New Dehli, India, 110029 Department of Neurological Sciences, Christian Medical College & Hospital Vellore, India, 632004 Israel Soroka Medical Center, Neurosurgery Department Beer Sheva, Israel Rambam Medical Center, Neurosurgery Department Haifa, Israel, 31096 Rabin Medical Center, Neurosurgery Department Petach Tikva, Israel, 49100 Russian Federation Sverdlovsk Regional Oncological Clinic Ekaterinburg, Russian Federation, 620036 Republican Clinical Hospital of Ministry of Health of Tatarstan Republic Kazan, Russian Federation, 420064 Burdenko Neurosurgery Research Institute Moscow, Russian Federation, 125047 Omsk State Medical Academy; State Educational Institution of Higher Professional Education Omsk, Russian Federation, 644099 State Institution of Healthcare, Samara Regional Clinical Hospital in the name of M.I. Kalinin Samara, Russian Federation, 443095 Polenov Neurosurgery Research Institute St. Petersburg, Russian Federation, 191104 Military Medical Academy named after I.S.M. Kirov, Neurosurgery Department St. Petersburg, Russian Federation, 194175 Medical Center "XXI century" St. Petersburg, Russian Federation, 194354 Tcheliabinsk Regional Clinical Hospital; State Medical Institution for Prophylaxis and Treatment Tcheliabinsk, Russian Federation, 454076 Less <<
NCT03609060 Acute Myeloid Leukemia Phase 2 Recruiting December 31, 2025 France ... More >> CHU ANGERS - Maladies du sang Recruiting Angers, France, 49933 Contact: Mathilde HUNAULT, Dr    02 41 35 45 82    mahunault@chu-angers.fr    Ch Avignon Not yet recruiting Avignon, France, 84000 Contact: Safia CHEBREK, Dr    +33 4 32 75 93 00    chebrek.safia@ch-avignon.fr    CH de la Côte Basque - Hématologie Not yet recruiting Bayonne, France, 64109 Contact: Anne BANOS, Dr    +33 5 59 44 38 32    abanos@ch-cotebasque.fr    CHRU JEAN MINJOZ - Hématologie Not yet recruiting Besançon, France, 25030 Contact: Yohan DESBROSSES, Dr    +33 3 81 66 82 32    ydesbrosses@chu-besancon.fr    CHU Brest - Hôpital Morvan - Hématologie Clinique Not yet recruiting Brest, France, 29609 Contact: Gaëlle GUILLERM, Dr    +33 2 98 22 35 04    gaelle.guillerm@chu-brest.fr    CH de Béziers - Hématologie Not yet recruiting Béziers, France, 34500 Contact: Alain SAAD, Dr    +33 4 67 35 70 63    alain.saad@ch-beziers.fr    Clinique du Parc - Hématologie Not yet recruiting Castelnau-le-Lez, France, 34170 Contact: Carole EXBRAYAT, Dr    +33 4 67 33 15 12    carole.exbrayat@groupeclinipole.fr    CHU Estaing - Hématologie Clinique Adulte Not yet recruiting Clermont-Ferrand, France, 63000 Contact: Romain GUIEZE, Dr    +33 4 73 75 00 65    rguieze@chu-clermontferrand.fr    CHU Grenoble - Hématologie Clinique Not yet recruiting Grenoble, France, 38043 Contact: Martin CARRE, Dr    +33 4 76 76 57 55    mcarre1@chu-grenoble.fr    Institut Paoli-Calmettes - Hématologie 2 Not yet recruiting Marseille, France, 13000 Contact: Norbert VEY, Pr    +33 4 91 22 36 95    veyn@ipc.unicancer.fr    CHR de Mercy - Hématologie Not yet recruiting Metz, France, 57085 Contact: Véronique DORVAUX, Dr    +33 3 87 55 33 04    v.dorvaux@chr-metz-thionville.fr    Hôpital Saint-Eloi - Hématologie Clinique Not yet recruiting Montpellier, France, 34295 Contact: Yosr HICHERI, Dr    +33 4 67 33 24 18    y-hicheri@chu-montpellier.fr    HOPITAL E. MULLER - Hématologie Not yet recruiting Mulhouse, France, 68070 Contact: Mario OJEDA-URIBE, Dr    +33(0)3 89 64 77 55    ojeda-uribem@ghrmsa.fr    CHU HOTEL DIEU - Hématologie Clinique Not yet recruiting Nantes, France, 44093 Contact: Pierre PETERLIN², Dr    +33(0)2 40 08 32 71    pierre.peterlin@chu-nantes.fr    CHR ORLEANS - Hématologie Recruiting Orléans, France, 44100 Contact: Omar BENBRAHIM, Dr    +33(0)2 38 22 99 27    omar.benbrahim@chr-orleans.fr    HOPITAL COCHIN - Hématologie Not yet recruiting Paris, France, 75014 Contact: Lise WILLEMS, Dr    +33(0)1 58 41 26 70    lise.willems@aphp.fr    CENTRE HOSPITALIER SAINTJEAN - Hématologie Clinique Not yet recruiting Perpignan, France, 66000 Contact: Laurence SANHES, Dr    +33(0)4 68 61 89 02    laurence.sanhes@ch-perpignan.fr    Hôpital Haut Levêque- CFM -Hématologie Clinique Et Thérapie Cellulaire Not yet recruiting Pessac, France, 33604 Contact: Arnaud PIGNEUX, Pr    +33 5 57 65 65 11    arnaud.pigneux@chu-bordeaux.fr    CHU La Milétrie - Hématologie Clinique Not yet recruiting Poitiers, France, 86000 Contact: Maria-Pilar GALLEGO-HERNANZ, Dr    +33(0)5 49 44 44 44    maria-pilar.gallego-hernanz@chu-poitiers.fr    CHU Reims - Hôpital Robert Debré - Hématologie Clinique Not yet recruiting Reims, France, 51100 Contact: Chantal HIMBERLIN, Dr    +33(0)3 26 78 36 44    chimberlin@chu-reims.fr    CHU Pontchaillou - Hématologie Not yet recruiting Rennes, France, 35033 Contact: Marc BERNARD, Dr    +33(0)2 99 28 99 86    marc.bernard@chu-rennes.fr    CHU Hautepierre - Hématologie Not yet recruiting Strasbourg, France, 67098 Contact: Bruno LIOURE, Dr    +33(0)3 88 12 76 76    bruno.lioure@chru-strasbourg.fr    Institut Universitaire du Cancer de Toulouse Oncopole - Service d'Hématologie Recruiting Toulouse, France, 31059 Contact: Christian RECHER, Pr    +33 5 31 15 63 55    recher.christian@iuct-oncopole.fr    CHU Bretonneau - Centre Henri Kaplan - Hématologie et Thérapie Cellulaire Not yet recruiting Tours, France, 37044 Contact: Emmanuel GYAN, Pr    +33(0)2 47 47 37 12    emmanuel.gyan@univ-tours.fr    CHU Nancy - Hopitaux Brabois Not yet recruiting Vandœuvre-lès-Nancy, France, 54500 Contact: Gabrielle ROTH-GUEPIN, Dr    +33(0)3 83 15 76 86    g.roth-guepin@chru-nancy.fr Less <<
NCT00925873 Acute Myeloid Leukemia Phase 3 Completed - France ... More >> GOELAMS Tours, France, 37000 Less <<
NCT03291314 Recurrent Glioblastoma (WHO-Gr... More >>ade IV Glioma) Less << Phase 2 Recruiting September 30, 2018 Belgium ... More >> UZ Brussel Recruiting Brussel, Belgium, 1090 Contact: Bart Neyns, Phd,Md    +32 2 477 ext 54 47    bart.neyns@uzbrussel.be    Principal Investigator: Bart Neyns, Phd,Md Less <<
NCT00003113 Lymphoma Phase 2 Terminated - United States, Ohio ... More >> Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 Less <<
NCT00088400 Glioblastoma Phase 3 Completed - United States, Maryland ... More >> National Institute of Neurological Disorders and Stroke (NINDS) Bethesda, Maryland, United States, 20892 Less <<
NCT00700544 AML Elderly P... More >>atients Less << Phase 3 Completed - France ... More >> Arnaud PIGNEUX Pessac, France, 33604 Less <<
NCT00335075 Glioblastoma ... More >>Astrocytoma Less << Phase 3 Completed - -
NCT01470794 Glioblastoma Multiforme ... More >> Anaplastic Astrocytoma Anaplastic Oligodendroglioma Anaplastic Oligoastrocytoma Less << Phase 1 Completed - United States, California ... More >> UCLA Los Angeles, California, United States, 90095 University of California at San Diego San Diego, California, United States, 92093 United States, Michigan Henry Ford Hospital Detroit, Michigan, United States, 48202 United States, New Jersey JFK Medical Center Edison, New Jersey, United States, 08820 Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 United States, Ohio Cleveland Clinic Foundation Cleveland, Ohio, United States, 44195 Ohio State University Columbus, Ohio, United States, 43210 United States, Washington Swedish Neuroscience Institute Seattle, Washington, United States, 98122 Less <<
NCT02296580 Glioblastoma Multiforme Not Applicable Recruiting December 2019 United States, Alabama ... More >> University of Alabama at Birmingham (UAB) Active, not recruiting Birmingham, Alabama, United States, 35233 United States, Arizona Center for Neurosciences Recruiting Tucson, Arizona, United States, 85718 Contact: Margie Pazzi, RN, MSN    520-320-2147    mpazzi@neurotucson.com    Contact    520.795.7750       Principal Investigator: Michael Badruddoja, MD          United States, California cCARE - California Cancer Associates for Research & Excellence Recruiting Encinitas, California, United States, 92024 Contact: Beth Kimball    760-452-3909    bkimball@ccare.com    Principal Investigator: Edward McClay, MD          John Wayne Cancer Institute @ Providecne St. Johns Health Center Recruiting Santa Monica, California, United States, 90404 Contact: Anand Moses    310-582-7097    mosesa@jwci.org    Principal Investigator: Garni Barkhoudarian, MD          United States, Connecticut Associated Neurologists of Southern CT, P.C. Recruiting Fairfield, Connecticut, United States, 06824 Contact: Tori Pascoe, CRC    203-333-1151 ext 4    tpascoe@anscneuro.com    Principal Investigator: Nicholas Blondin, MD          United States, Florida Boca Raton Regional Hospital Recruiting Boca Raton, Florida, United States, 33486 Contact: Pilar Zuniga, MD    561-955-4800    pzuniga@brrh.com    Principal Investigator: Sajeel Chowdhary, MD          United States, Kansas University of Kansas Medical Center (KUMC) Recruiting Kansas City, Kansas, United States, 66205 Contact: Sasha Moores    913-588-5520    smoores@kumc.edu    Principal Investigator: Michael Salacz, MD          United States, Oregon Providence Brain & Spine Institute Recruiting Portland, Oregon, United States, 97225 Contact: Kyla Lindberg    503-202-7934    Kyla.Lindberg@Providence.org    Principal Investigator: Ricky Chen, MD          United States, Texas Cancer Care Collaborative Recruiting Austin, Texas, United States, 78705 Contact: Heidi Herndon, RN    512-324-7000 ext 77713    hherndon@ascension.org    Principal Investigator: Brian D Vaillant, MD          Baylor Scott & White Health Recruiting Temple, Texas, United States, 76508 Contact: Dedra Preece, BS, CCRP    254-724-5939    dedra.preece@bswhealth.org    Contact: Gates Anderson    254.724.5889    Gates.Anderson@bswhealth.org    Principal Investigator: Ekokobe Fonkem, DO          United States, Washington Virginia Mason Hospital & Medical Center Active, not recruiting Seattle, Washington, United States, 98101 Swedish Medical Center Active, not recruiting Seattle, Washington, United States, 98122 Australia St Vincent's Hospital Melbourne Recruiting Melbourne, Australia Contact: Emma Priest    03 9231 3551    emma.priest@svha.org.au    Principal Investigator: Anthony Dowling, MD Less <<
NCT00053872 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 3 Unknown - Belgium ... More >> U.Z. Gasthuisberg Leuven, Belgium, B-3000 France Institut Curie Hopital Paris, France, 75248 Germany Universitaets - Kinderklinik Wuerzburg Wuerzburg, Germany, D-97080 Italy Ospedale Infantile Regina Margherita Turin, Italy, 10126 Netherlands Academisch Medisch Centrum at University of Amsterdam Amsterdam, Netherlands, 1105 AZ Spain Hospital de Cruces Vizcaya, Spain, 48 Sweden Ostra Sjukhuset Gothenburg, Sweden, 41685 United Kingdom Royal Liverpool Children's Hospital, Alder Hey Liverpool, England, United Kingdom, L12 2AP Less <<
NCT02444000 Anaplastic Gliomas With 1p/19q... More >> Codeletion Less << Phase 3 Recruiting June 2024 France ... More >> Groupe Hospitalier Pitié Salpetriere Recruiting Paris, France, 75013 Contact: Jean-Yves Delattre, MD, PhD    +33(0) 1 42 16 03 85    jean-yves.delattre@aphp.fr Less <<
NCT02076152 Recurrent Glioblastoma Not Applicable Recruiting January 2020 United States, Massachusetts ... More >> Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 01852 Contact: Tracy Batchelor, MD    617-724-8770    tbatchelor@partners.org    Principal Investigator: Tracy Batchelor, MD Less <<
NCT03678883 Cancer Lympho... More >>ma Pancreatic Cancer Glioblastoma Multiforme Sarcoma Breast Cancer Bladder Cancer Renal Cancer Ovarian Cancer Refractory Cancer Refractory Neoplasm Refractory Non-Hodgkin Lymphoma Refractory Brain Tumor Pancreatic Adenocarcinoma Resistant Cancer Neoplasm Metastasis Neoplasm of Bone Neoplasm, Breast Neoplasm of Lung Neoplasms,Colorectal Neoplasms Pancreatic Malignant Glioma Malignancies Malignancies Multiple Bone Metastases Bone Neoplasm Bone Cancer Pancreas Cancer Pancreatic Neoplasms Breast Neoplasms Less << Phase 1 Phase 2 Recruiting November 2022 United States, Rhode Island ... More >> Rhode Island Hospital Recruiting Providence, Rhode Island, United States, 02903 Contact: Benedito Carneiro, MD       Benedito.Carneiro@Lifespan.org Less <<
NCT02066220 Brain Tumors Phase 2 Phase 3 Recruiting April 2024 -
NCT00227500 HIV Infections ... More >> Lipid Metabolism Glucose Metabolism Metabolic Abnormality Lipodystrophy Cardiovascular Disease Less << Phase 4 Completed - Australia, New South Wales ... More >> St. Vincents Hospital Sydney, New South Wales, Australia, 2010 Less <<
NCT00717210 Anaplastic Astrocytoma ... More >> Oligodendroglioma Oligoastrocytoma Less << Phase 3 Completed - Germany ... More >> University of Heidelberg Heidelberg, Baden-Württemberg, Germany, 69120 Neurology and Radiotherapy Tübingen, Baden-Württemberg, Germany, 72076 Klinikum Aschaffenburg Aschaffenburg, Germany Nervenklinik Bamberg, Germany Charite Berlin, Germany Neurosurgery Düsseldorf, Germany Radiotherapy Erlangen, Germany Neurology Essen, Germany Neurosurgery Frankfurt, Germany Neurosurgery Kiel, Germany Neurosurgery Mainz, Germany County District Hospital Regensburg, Germany Less <<
NCT00418743 - Unknown May 2010 France ... More >> Centre Hospitalier Universitaire Recruiting Angers, France, 49033 Contact: Thierry URBAN, Doctor    +33241355844    thurban@chu-angers.fr    Principal Investigator: Thierry URBAN, Doctor          Sub-Investigator: Nathalie BAIZE, Doctor          Sub-Investigator: Thierry JEANFAIVRE, Doctor          Sub-Investigator: José HUREAUX, Doctor          Site 05 Recruiting Bastia, France, 20200 Contact: Jean Cl MOURIES, Doctor    +33495591080    jcmouries@ch-bastia.fr    Principal Investigator: Jean Cl MOURIES, Doctor          Site 22 Recruiting Beauvais, France, 60021 Contact: Eric BOUCHAERT, Doctor          Principal Investigator: Eric BOUCHAERT, Doctor          Centre Hospitalier du Morvan Recruiting Brest, France, 29200 Contact: Gilles ROBINET, Doctor    +33298223428    gilles.robinet@chu-brest.fr    Principal Investigator: Gilles ROBINET, Doctor          Centre François Baclesse Recruiting Caen, France, 14000 Contact: Radj GERVAIS, Doctor    +33231455013    r.gervais@baclesse.fr    Principal Investigator: Radj GERVAIS, Doctor          Site 43 Recruiting Caen, France, 14000 Contact: Radj GERVAIS, Professor          Principal Investigator: Radj GERVAIS, Professor          Centre Hospitalier René Dubos Recruiting Cergy-pontoise, France, 95301 Contact: Gislaine FRABOULET, Doctor    +33130754282    gislaine.fraboulet@ch-pontoise.fr    Principal Investigator: Gislaine FRABOULET, Doctor          Site 33 Recruiting Creteil, France, 94010 Contact: Isabelle MONNET, Doctor          Principal Investigator: Isabelle MONNET, Doctor          Site 07 Recruiting Draguignan, France, 83300 Contact: Hervé LECAER, Doctor    +33 4 94 60 51 12    herve.lecaer@ch-draguignan.fr    Principal Investigator: Hervé LE CAER, Doctor          Site 32 Recruiting Elbeuf, France, 76503 Contact: Philippe DAVID          Principal Investigator: Philippe DAVID, Professor          Site 04 Recruiting GAP, France, 05000 Contact: Pascal THOMAS, Doctor    +33 4 92 40 61 26    pascal.thomas@chicas-gap.fr    Principal Investigator: Pascal THOMAS, Doctor          Centre Hospitalier Les Oudairies Recruiting La Roche Sur Yon, France, 85000 Contact: Acya BIZIEUX-TAMINY, Doctor    +33251446164    acya.bizieux@chd-vendee.fr    Principal Investigator: Acya BIZIEUX-TAMINY, Doctor          Sub-Investigator: Marie MARCQ, Doctor          Hospital du Cluzeau Recruiting Limoges, France, 87042 Contact: Alain VERGNENEGRE, Professor    +33 5 55 05 66 29    avergne@unilim.fr    Principal Investigator: Alain VERGNENEGRE, Professor          Centre Hospitalier Régional Recruiting Longjumeau, France, 91160 Contact: Gérard OLIVIERO, Doctor    +33164543181    gerard.oliviero@ch-longjumeau.fr    Principal Investigator: Gérard OLIVIERO, Doctor          Sub-Investigator: Pascal ASSOULINE, Doctor          Centre Hospitalier Lyon Sud Recruiting Lyon, France, 69495 Contact: Laurence GERINIERE, Doctor    +33478861328    lairence.geriniere@chu-lyon.fr    Principal Investigator: Laurence GERINIERE, Doctor          Sub-Investigator: Pierre J SOUQUET, Professor          Site 25 Recruiting Mantes La Jolie, France, 78200 Contact: Jean B AULIAC, Doctor          Principal Investigator: Jean Be AULIAC, Doctor          Site 06 Recruiting Marseille, France, 13274 Contact: Fabrice BARLESI, Doctor    +33 4 91 74 47 36    fabrice.barlesi@aphm.fr    Principal Investigator: Fabrice BARLESI, Professor          Sub-Investigator: Laurent GREILLIER, Doctor          Sub-Investigator: Philippe ASTOUL, Professor          Site 27 Recruiting Martigues, France, 13695 Contact: Hervé JULLIAN, Doctor          Principal Investigator: Hervé JULLIAN, Doctor          Site 01 Recruiting Meaux, France, 77108 Contact: Francois BLANCHON, Doctor    +33 1 64 35 38 56    f-blanchon@ch-meaux.fr    Principal Investigator: Francois BLANCHON, Doctor          Hospital Saint Antoine Recruiting Paris, France, 75012 Contact: Christos CHOUAID, Professor    +33 1 48 28 25 16    christos.chouaid@sat.ap-hop-paris.fr    Principal Investigator: Christos CHOUAID, Professor          Site 17 Recruiting Rouen, France, 76233 Contact: Dominique PAILLOTIN, DOCTOR          Principal Investigator: Dominique PAILLOTIN, Doctor          Hôpital Yves Le Foll Recruiting Saint Brieuc, France, 22023 Contact: Gwenaelle LE GARFF, Doctor    +33296017123    gwenaelle.legarff@ch-stbrieuc.fr    Principal Investigator: Gwenaelle LE GARFF, Doctor          Site 14 Recruiting Toulon, France, 83800 Contact: Henri BERARD, Doctor          Principal Investigator: Henri BERARD, Doctor          Site 11 Recruiting Villefranche Sur Saone, France, 69655 Contact: Lionel FALCHERO, Doctor    +33 4 74 09 27 23       Principal Investigator: Lionel FALCHERO, Doctor Less <<
NCT00003375 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Phase 3 Completed - -
NCT00085735 Untreated Childhood Medullobla... More >>stoma Less << Phase 3 Completed - -
NCT00002569 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 3 Completed - -
NCT00002944 Brain Tumors ... More >>Central Nervous System Tumors Less << Phase 3 Completed - -
NCT00003603 Multiple Myeloma and Plasma Ce... More >>ll Neoplasm Less << Phase 3 Unknown - United Kingdom ... More >> Hammersmith Hospital London, England, United Kingdom, W12 ONN Less <<
NCT00085735 - Completed - -
NCT00887146 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 3 Recruiting - -
NCT02212574 Medulloblastoma Not Applicable Recruiting May 2022 United States, Arizona ... More >> Phoenix Childrens Hospital Hematology/Oncology Recruiting Phoenix, Arizona, United States, 85016-7710 Contact: Michael Etzl, Dr    602-546-0920    metzl@phoenixchildrens.com    United States, Colorado Children's Hospital Colorado Center for Cancer & Blood Disorders Recruiting Aurora, Colorado, United States, 80045 Contact: Kathleen Dorris, M.D., M.S.    720-777-6772    kathleen.dorris@childrenscolorado.org    United States, Florida M D Anderson Cancer Center-Orlando Pediatric Hematology/Oncology Not yet recruiting Orlando, Florida, United States, 32806 Contact: Amy Smith, Dr    321-841-8588    amy.smith@orlandohealth.com    All Children's Hospital Pediatric Hematology/Oncology Recruiting Saint Petersburg, Florida, United States, 33701 Contact: Stacie Stapleton, Dr    727-767-4176    Stacie.Stapleton@allkids.org    United States, Georgia Children's Healthcare of Atlanta- Egleston Pediatric Neuro-Oncology Recruiting Atlanta, Georgia, United States, 30322 Contact: Tobey MacDonald, Dr    404-727-1447    tobey.macdonald@emory.edu    United States, Illinois Ann and Robert H Lurie Children's Hospital of Chicago Hematology/Oncology Recruiting Chicago, Illinois, United States, 60611 Contact: Stewart Goldman, Dr    312-227-4844    sgoldman@northwestern.edu    United States, Maryland Johns Hopkins University Recruiting Baltimore, Maryland, United States, 21287 Contact: Kenneth Cohen, MD, MBA    410-614-5055    kcohen@jhmi.edu    Contact: Tammy Scott, RN    4140-614-5990    scottta@jhmi.edu    United States, Massachusetts Dana-Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 Contact: Pratiti Bandopadhayay, MBBS, PhD          United States, Missouri Washington University School of Medicine Pediatric Hematology/Oncology Recruiting Saint Louis, Missouri, United States, 63110 Contact: Joshua Rubin, Dr    314-454-6018    rubin_j@kids.wustl.edu    United States, New Jersey Hackensack University Medical Center Recruiting Hackensack, New Jersey, United States, 07601 Contact: Derek Hanson, MD    551-996-5437    dhanson@hackensackumc.org    United States, New York Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Kevin De Braganca, MD    212-639-3449    debragak@mskcc.org    United States, North Carolina Duke University Medical Center Recruiting Durham, North Carolina, United States, 27705 Contact: David Ashley, MD, PhD       david.ashley@duke.edu    Principal Investigator: David Ashley, MD, PhD          United States, Ohio Nationwide Children's Hospital Recruiting Columbus, Ohio, United States, 43205 Contact: Mohamed S AbdelBaki, MBBCh    614-722-3250    mohamed.abdelbaki@nationwidechildrens.org    United States, Oregon Oregon Health and Science University Pediatric Hematology/Oncology Not yet recruiting Portland, Oregon, United States, 97239-3098 Contact: Kellie Nazemi, Dr    503-494-0714    nazemik@ohsu.edu    United States, Washington Seattle Children's Hospital Hematology/Oncology Recruiting Seattle, Washington, United States, 98105 Contact: Sarah Leary, Dr    206-987-2106    sarah.leary@seattlechildrens.org    United States, Wisconsin Childrens Hospital of Wisconsin (Medical College of Wisconsin) Recruiting Milwaukee, Wisconsin, United States, 53226 Contact: Jeffrey Knipstein, MD    414-955-4108    jknipstein@jhmi.edu Less <<
NCT03463265 High Grade Recurrent Glioma an... More >>d Newly Diagnosed Glioblastoma Less << Phase 2 Recruiting June 2021 United States, California ... More >> John Wayne Cancer Institute Recruiting Santa Monica, California, United States, 90404 Contact: Najee Boucher    310-582-7460    najee.boucher@providence.org Less <<
NCT00049439 Lymphoma Phase 2 Completed - United States, New York ... More >> Herbert Irving Comprehensive Cancer Center at Columbia University New York, New York, United States, 10032 United States, Ohio Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 Kenya University of Nairobi College of Health Sciences Nairobi, Kenya Uganda Uganda Cancer Institute Kampala, Uganda Less <<
NCT00005796 Bone Marrow Suppression ... More >> Brain and Central Nervous System Tumors Drug/Agent Toxicity by Tissue/Organ Less << Phase 1 Completed - United States, Indiana ... More >> Indiana University Cancer Center Indianapolis, Indiana, United States, 46202-5265 United States, Massachusetts Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT02843230 - Recruiting August 31, 2021 United States, Massachusetts ... More >> Massachusetts general Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Eva-Maria Ratai, PhD    617-726-1744    eratai@mgh.harvard.edu    Principal Investigator: Eva-Maria Ratai, PhD Less <<
NCT00004259 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 3 Completed - -
NCT00004259 - Completed - -
NCT02333513 Recurrent High-grade Glioma Not Applicable Unknown December 2017 China, Beijing ... More >> Beijing Tiantan Hospital Not yet recruiting Beijing, Beijing, China, 100050 Contact: Nan Ji, Medical Doctor    +86 15210503095    neurochina@sohu.com    China, Hebei Hebei Yanda Hospital Not yet recruiting Sanhe, Hebei, China, 065200 Contact: Nan Ji, Medical Doctor    +86 15210503095    neurochina@sohu.com Less <<
NCT01775475 AIDS-related Diffuse Large Cel... More >>l Lymphoma AIDS-related Diffuse Mixed Cell Lymphoma AIDS-related Diffuse Small Cleaved Cell Lymphoma AIDS-related Immunoblastic Large Cell Lymphoma AIDS-related Lymphoblastic Lymphoma AIDS-related Peripheral/Systemic Lymphoma AIDS-related Small Noncleaved Cell Lymphoma Stage III AIDS-related Lymphoma Stage IV AIDS-related Lymphoma Less << Phase 2 Active, not recruiting February 2021 Kenya ... More >> Moi Teaching and Referral Hospital Eldoret, Kenya, 4606-30100 Zimbabwe University of Zimbabwe College of Health Sciences Harare, Zimbabwe Less <<
NCT00989352 Primary Non Hodgkin Lymphoma o... More >>f the Central Nervous System Less << Phase 2 Unknown September 2011 Germany ... More >> University Medical Center Freiburg, Dept. of Internal Medicine I - Hematology and Oncology Recruiting Freiburg, Germany, 79106 Contact: Gerald Illerhaus, PD Dr.    +497612703785    Gerald.Illerhaus@uniklinik-freiburg.de    Contact: Elvira Burger    +497612707378    elvira.burger@uniklinik-freiburg.de    Principal Investigator: Gerald Illerhaus, PD Dr. Less <<
NCT00761280 Anaplastic Astrocytoma ... More >> Glioblastoma Less << Phase 3 Terminated(Unable to recruit t... More >>he projected patient number. All analyses are descriptive, only.) Less << - -
NCT00031590 Brain Tumors ... More >>Central Nervous System Tumors Medulloblastoma Primitive Neuroectodermal Tumor Less << Phase 2 Terminated(The study was termi... More >>nated prematurely due to slow accrual.) Less << - United States, California ... More >> Lucile Packard Children's Hospital at Stanford University Medical Center Palo Alto, California, United States, 94304 United States, Georgia Winship Cancer Institute of Emory University Atlanta, Georgia, United States, 30322 United States, Pennsylvania Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104-4318 Less <<
NCT00002840 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 3 Completed - -
NCT02678975 Glioma Gliobl... More >>astoma Less << Phase 2 Phase 3 Recruiting September 2020 Norway ... More >> Cancer Clinic, St.Olavs University Hospital Recruiting Trondheim, Norway Contact: Tora S Solheim, MD, PhD          Principal Investigator: Tora S Solheim, MD, PhD          Sweden Dept. of Oncology, Sahlgrenska University Hospital Recruiting Gothenburg, Sweden Contact: Katja Werlenius, MD          Principal Investigator: Katja Werlenius, MD          Ryhov County Hospital Recruiting Jönköping, Sweden Contact: Michael Strandéus, MD          Principal Investigator: Michael Strandéus, MD          Linköping University Hospital Recruiting Linkoping, Sweden Contact: Munila Mudaisi, MD          Principal Investigator: Munila Mudaisi, MD          Lund University Hospital Recruiting Lund, Sweden Contact: Sara Kinhult, MD, PhD          Principal Investigator: Sara Kinhult, MD, PhD          Karolinska University Hospital Recruiting Stockholm, Sweden Contact: Sofia Hylin, MD          Principal Investigator: Sofia Hylin, MD          Uppsala University Hospital Recruiting Uppsala, Sweden Contact: Magnus Lindskog, MD, PhD          Principal Investigator: Magnus Lindskog, MD, PHD          Örebro University Hospital Recruiting Örebro, Sweden Contact: David Löfgren, MD          Principal Investigator: David Löfgren, MD Less <<
NCT00003114 Lymphoma Phase 2 Completed - United States, Ohio ... More >> Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 Less <<
NCT02724579 Medulloblastoma ... More >> Untreated Childhood Medulloblastoma Less << Phase 2 Recruiting May 31, 2025 -
NCT03149575 Glioblastoma Multiforme ... More >> Glioblastoma Glioma GBM Brain Cancer Less << Phase 3 Active, not recruiting August 2019 United States, California ... More >> Kaiser Permanente Los Angeles Medical Center Los Angeles, California, United States, 90027 University of California, San Francisco - Division of Neuro-Oncology San Francisco, California, United States, 94143 United States, Minnesota Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 United States, New Jersey Atlantic Neuroscience Institute - Brain Tumor Center of NJ Summit, New Jersey, United States, 07901 United States, New York Dent Neurosciences Research Center Amherst, New York, United States, 14226 Less <<
NCT00002806 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Completed - United States, Arizona ... More >> CCOP - Scottsdale Oncology Program Scottsdale, Arizona, United States, 85259-5404 United States, Illinois CCOP - Carle Cancer Center Urbana, Illinois, United States, 61801 United States, Iowa CCOP - Cedar Rapids Oncology Project Cedar Rapids, Iowa, United States, 52403-1206 CCOP - Iowa Oncology Research Association Des Moines, Iowa, United States, 50309-1016 Siouxland Hematology-Oncology Sioux City, Iowa, United States, 51101-1733 United States, Kansas CCOP - Wichita Wichita, Kansas, United States, 67214-3882 United States, Michigan CCOP - Ann Arbor Regional Ann Arbor, Michigan, United States, 48106 United States, Minnesota CCOP - Duluth Duluth, Minnesota, United States, 55805 Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 CCOP - Metro-Minnesota Saint Louis Park, Minnesota, United States, 55416 United States, North Dakota Quain & Ramstad Clinic, P.C. Bismarck, North Dakota, United States, 58501 CCOP - Merit Care Hospital Fargo, North Dakota, United States, 58122 Altru Health Systems Grand Forks, North Dakota, United States, 58201 United States, Ohio CCOP - Toledo Community Hospital Oncology Program Toledo, Ohio, United States, 43623-3456 United States, Pennsylvania CCOP - Geisinger Clinical and Medical Center Danville, Pennsylvania, United States, 17822-2001 United States, South Dakota Rapid City Regional Hospital Rapid City, South Dakota, United States, 57709 CCOP - Sioux Community Cancer Consortium Sioux Falls, South Dakota, United States, 57105-1080 Less <<
NCT00761280 - Terminated(Unable to recruit t... More >>he projected patient number. All analyses are descriptive, only.) Less << - -
NCT00276666 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Unknown - Ireland ... More >> Our Lady's Hospital for Sick Children Crumlin Dublin, Ireland, 12 United Kingdom Birmingham Children's Hospital Birmingham, England, United Kingdom, B4 6NH Institute of Child Health at University of Bristol Bristol, England, United Kingdom, BS2 8AE Addenbrooke's Hospital Cambridge, England, United Kingdom, CB2 2QQ Cookridge Hospital Leeds, England, United Kingdom, LS16 6QB Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom, LS9 7TF Leicester Royal Infirmary Leicester, England, United Kingdom, LE1 5WW Royal Liverpool Children's Hospital, Alder Hey Liverpool, England, United Kingdom, L12 2AP Royal London Hospital London, England, United Kingdom, E1 1BB Great Ormond Street Hospital for Children London, England, United Kingdom, WC1N 3JH Royal Manchester Children's Hospital Manchester, England, United Kingdom, M27 4HA Sir James Spence Institute of Child Health at Royal Victoria Infirmary Newcastle-Upon-Tyne, England, United Kingdom, NE1 4LP Queen's Medical Centre Nottingham, England, United Kingdom, NG7 2UH Oxford Radcliffe Hospital Oxford, England, United Kingdom, 0X3 9DU Children's Hospital - Sheffield Sheffield, England, United Kingdom, S10 2TH Southampton General Hospital Southampton, England, United Kingdom, SO16 6YD Royal Marsden - Surrey Sutton, England, United Kingdom, SM2 5PT Royal Belfast Hospital for Sick Children Belfast, Northern Ireland, United Kingdom, BT12 6BE Royal Aberdeen Children's Hospital Aberdeen, Scotland, United Kingdom, AB25 2ZG Royal Hospital for Sick Children Edinburgh, Scotland, United Kingdom, EH9 1LF Royal Hospital for Sick Children Glasgow, Scotland, United Kingdom, G3 8SJ Childrens Hospital for Wales Cardiff, Wales, United Kingdom, CF14 4XW Less <<
NCT00002875 Brain Tumors ... More >>Central Nervous System Tumors Less << Phase 3 Completed - -
NCT02414165 Glioblastoma Multiforme ... More >> Anaplastic Astrocytoma Less << Phase 2 Phase 3 Active, not recruiting March 2023 -
NCT00003929 Lymphoma Phase 2 Withdrawn - United States, Ohio ... More >> Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 Less <<
NCT02869087 Peripheral Vascular Disease Not Applicable Recruiting October 2020 Austria ... More >> LKH University Hospital Graz Recruiting Graz, Steiermark, Austria, A8036 Contact: Marianne Brodmann, Dr       marianne.brodmann@medunigraz.at    Hanusch Hospital Recruiting Vienna, Austria, 1140 Contact: Martin Werner, Dr       office@drwerner.eu    Belgium AZ Sint Blasius, Dendermonde Recruiting Dendermonde, Brussels, Belgium Contact: Marc Bosiers, Doctor       'marc.bosiers@telenet.be    Contact: Jeroen Wauters, Mr    '+32 52252822    jeroen.wauters@fmrp.be    Principal Investigator: Marc Bosiers, Dr          Onze-Leve Vrouwziekenhuis Withdrawn Aalst, Belgium, 9300 Imelda Hospital Withdrawn Bonheiden, Belgium Heilig Hart Hospital Recruiting Tienen, Belgium Contact: Koen Keirse, Dr       koen.keirse@rztienen.be    Principal Investigator: Koen Keirse, Dr          Germany Bonifatius Hospital Recruiting Lingen, Niedersachsen, Germany, 49808 Contact: Joerg Tessarek, Dr       Joerg.Tessarek@hospital-lingen.de    Klinikum Arnsberg Recruiting Arnsberg, NRW, Germany, 59759 Contact: Michael Lichtenberg, Dr       mlichtenberg@klinikum-arnsberg.de    Heart Center Bad Krozingen Recruiting Freiburg, Germany Contact: Thomas Zeller, Doctor       thomas.zeller@universitaets-herzzentrum.de    Principal Investigator: Thomas Zeller, Dr          Universitätsklinikum Leipzig AöR, Recruiting Leipzig, Germany Contact: Dierk Scheinert, Dr       Dierk.Scheinert@medizin.uni-leipzig.de    Principal Investigator: Dierk Scheinert, Dr          St Franziskus Hospital Recruiting Muenster, Germany Contact: Giovanni Torsello, Doctor       giovanni.torsello@sfh-muenster.de    Principal Investigator: Giovanni Torsello, Dr          Netherlands St Antonius Ziekenhuis Withdrawn Nieuwegein, Netherlands, 3430 New Zealand Auckland City Hospital Recruiting Auckland, New Zealand Contact: Andrew Holden, Dr    64-9 3074949    AndrewH@adhb.govt.nz    Principal Investigator: Andrew Holden, Dr          Wellington Hospital Recruiting Wellington, New Zealand Contact: Kes Wicksemesekera, Dr          Contact: Marina Dzhelali    644 918 5117    marina.dzhelali@ccdhb.org.nz Less <<
NCT00052455 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 3 Completed - United Kingdom ... More >> Medical Research Council Clinical Trials Unit London, England, United Kingdom, NW1 2DA Less <<
NCT00274911 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Unknown - Ireland ... More >> Our Lady's Hospital for Sick Children Crumlin Dublin, Ireland, 12 United Kingdom Birmingham Children's Hospital Birmingham, England, United Kingdom, B4 6NH Institute of Child Health at University of Bristol Bristol, England, United Kingdom, BS2 8AE Addenbrooke's Hospital Cambridge, England, United Kingdom, CB2 2QQ Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom, LS9 7TF Leicester Royal Infirmary Leicester, England, United Kingdom, LE1 5WW Royal Liverpool Children's Hospital, Alder Hey Liverpool, England, United Kingdom, L12 2AP Royal London Hospital London, England, United Kingdom, E1 1BB Great Ormond Street Hospital for Children London, England, United Kingdom, WC1N 3JH Royal Manchester Children's Hospital Manchester, England, United Kingdom, M27 4HA Sir James Spence Institute of Child Health at Royal Victoria Infirmary Newcastle-Upon-Tyne, England, United Kingdom, NE1 4LP Queen's Medical Centre Nottingham, England, United Kingdom, NG7 2UH Oxford Radcliffe Hospital Oxford, England, United Kingdom, 0X3 9DU Children's Hospital - Sheffield Sheffield, England, United Kingdom, S10 2TH Southampton General Hospital Southampton, England, United Kingdom, SO16 6YD Royal Marsden - Surrey Sutton, England, United Kingdom, SM2 5PT Royal Belfast Hospital for Sick Children Belfast, Northern Ireland, United Kingdom, BT12 6BE Royal Aberdeen Children's Hospital Aberdeen, Scotland, United Kingdom, AB25 2ZG Royal Hospital for Sick Children Edinburgh, Scotland, United Kingdom, EH9 1LF Royal Hospital for Sick Children Glasgow, Scotland, United Kingdom, G3 8SJ Childrens Hospital for Wales Cardiff, Wales, United Kingdom, CF14 4XW Less <<
NCT01614132 Medulloblastoma Phase 1 Phase 2 Active, not recruiting March 2021 Germany ... More >> Vivantes Netzwerk für Gesundheit GmbH Berlin, Germany, 10249 Neurologische Universitätsklinik Bochum, Germany, 44892 Universitätsklinikum Bonn Bonn, Germany, 53105 Universitätsklinikum Freiburg Freiburg, Germany, 79106 Medizinische Hochschule Hannover Hannover, Germany, 30625 Universitätsklinikum Heidelberg Heidelberg, Germany, 69120 Universitätsklinikum Leipzig Leipzig, Germany, 04103 Universitätsklinikum Schleswig-Holstein Lübeck, Germany, 23538 Otto-von-Guericke Universität Magdeburg, Germany, 39120 Johannes Gutenberg-Universität Mainz Mainz, Germany, 55131 Universitätsklinikum Münster Münster, Germany, 48149 Universitätsklinikum Regensburg Regensburg, Germany, 93053 Katharinenhospital Stuttgart, Germany, 70174 Universitätsklinikum Tübingen Tübingen, Germany, 72076 Universitätsklinikum Ulm Ulm, Germany, 89081 Less <<
NCT00504660 Anaplastic Glioma of Brain ... More >> Glioblastoma Multiforme Brain Cancer Less << Phase 2 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00074191 Lymphoma Phase 2 Completed - United States, Oregon ... More >> Oregon Health & Science University Cancer Institute Portland, Oregon, United States, 97239-3098 Less <<
NCT02926222 Glioblastoma Multiforme Phase 2 Active, not recruiting October 2018 Italy ... More >> IRCCS "Saverio de Bellis Castellana Grotte, BA, Italy, 70013 Ospedale di Bellaria Bologna, BO, Italy Azienda Ospedaliera "G.Rummo" Benevento, BR, Italy istituto Scientifico Romagnolo per lo Studio e Cura dei Tumori Cesena, FC, Italy, 47014 Istituto Neurologico C. Besta IRCCS Milano, MI, Italy, 20133 Istituto Oncologico Veneto IRCCS, Oncologia Medica 1 Padova, PD, Italy, 35128 Ospedale Santa Chiara Pisa, PI, Italy, 56126 Azienda Ospedaliero Universitaria S. Maria della Misericordia Udine, UD, Italy, 33100 Istituto Nazionale Tumori Regina Elena Roma, Italy, 00144 Azienda Ospedaliera Universitaria Città della Salute e della Scienza Torino, Italy, 10126 Less <<
NCT00072345 Intraocular Melanoma ... More >> Melanoma (Skin) Less << Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT01582269 Glioblastoma Phase 2 Active, not recruiting December 31, 2019 -
NCT03022578 Malignant Neoplasms of Eye Bra... More >>in and Other Parts of Central Nervous System Glioblastoma Anaplastic Astrocytoma Less << Phase 2 Recruiting November 2021 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact       bjobrien@mdanderson.org Less <<
NCT00068952 Glioblastoma Phase 3 Completed - -
NCT01682187 Glioma Phase 1 Active, not recruiting May 1, 2019 United States, Maryland ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Baltimore, Maryland, United States Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Barcelona, Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Madrid, Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sevilla, Spain Less <<
NCT03758014 GBM Phase 2 Phase 3 Recruiting April 30, 2021 China, Beijing ... More >> Beijing Tiantan Hospital, Capital Medical University Recruiting Beijing, Beijing, China Contact: Wenbin Li Less <<
NCT00504660 - Completed - -
NCT01290939 Glioblastoma Multiforme ... More >> Cognition Disorders Disability Evaluation Less << Phase 3 Active, not recruiting August 2018 Netherlands ... More >> Medisch Centrum Haaglanden - Westeinde Den Haag, Netherlands Erasmus MC - Daniel den Hoed Cancer Center Rotterdam, Netherlands Less <<
NCT00100802 - Unknown - -
NCT00777153 - Completed - -
NCT00777153 Recurrent Glioblastoma Phase 3 Completed - -
NCT01860638 Glioblastoma Phase 2 Completed - -
NCT02343406 Glioblastoma Multiforme Phase 2 Recruiting December 13, 2020 -
NCT03025893 Glioblastoma Multiforme ... More >> Glioblastoma, Adult Glioblastoma Recurrent Brain Tumor GBM Less << Phase 2 Phase 3 Recruiting January 2020 Netherlands ... More >> VU University Medical Center Recruiting Amsterdam, Netherlands Contact: Cyrillo G Brahm, MD    +31 20 444 4321       Principal Investigator: Henk WM Verheul, MD PhD          Sub-Investigator: Cyrillo G Brahm, MD          University Medical Center Groningen Not yet recruiting Groningen, Netherlands Contact: Cyrillo G Brahm, MD PhD          Principal Investigator: Annemiek ME Walenkamp, MD PhD          Sub-Investigator: Cyrillo G Brahm, MD Less <<
NCT00948389 Glioblastoma Phase 1 Phase 2 Terminated(Inability to meet p... More >>rotocol objectives) Less << - France ... More >> Local Institution Paris Cedex, France, 75013 Italy Local Institution Bologna, Italy, 40139 Netherlands Local Institution Nijmegen, Netherlands, 6525 GA Local Institution Rotterdam, Netherlands, 3075 EA Switzerland Local Institution Lausanne, Switzerland, 1011 Less <<
NCT00100802 Brain Tumors ... More >>Central Nervous System Tumors Less << Phase 2 Unknown - -
NCT00948389 - Terminated(Inability to meet p... More >>rotocol objectives) Less << - -
NCT00293280 Lung Cancer Phase 2 Completed - United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 Less <<
NCT01934361 Recurrent Glioblastoma Multifo... More >>rme Less << Phase 1 Completed - United States, Arizona ... More >> Barrow Neurological Insitute St. Joseph's Hospital Phoenix, Arizona, United States, 85013 United States, Arkansas Highlands Oncology Group Fayetteville, Arkansas, United States, 72703 United States, Illinois Northwestern University Chicago, Illinois, United States, 60611 United States, Massachusetts Dana Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, Texas MD Anderson Cancer Center/University of Texas Houston, Texas, United States, 77030 Australia, Victoria Novartis Investigative Site Heidelberg, Victoria, Australia, 3084 Novartis Investigative Site Parkville, Victoria, Australia, 3050 Belgium Novartis Investigative Site Leuven, Belgium, 3000 Canada, Ontario Novartis Investigative Site Toronto, Ontario, Canada, M5G 1Z6 France Novartis Investigative Site Marseille Cedex 05, France, 13885 Novartis Investigative Site Paris Cedex 13, France, 75651 Novartis Investigative Site Saint Herblain cedex, France, 44805 Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08036 Novartis Investigative Site Hospitalet de LLobregat, Catalunya, Spain, 08907 Less <<
NCT01149109 Glioblastoma Phase 3 Completed - Germany ... More >> Depatment of Neurosurgery, Charité, University Hospital Berlin Berlin, Germany, 13353 Department of Neurology, University Hospital Bochum Bochum, Germany, 44892 Department of Neurology, University Hospital Bonn Bonn, Germany, 53105 Department of Neurosurgery, University Hospital Cologne Cologne, Germany, 50937 Department of Neurosurgery, University Hospital Dresden Dresden, Germany, 01307 Department of Neurosurgery, University Hospital Duesseldorf Duesseldorf, Germany, 40225 Department of Neurosurgery, University Hospital Frankfurt Frankfurt, Germany, 60528 Department of Radiooncology, University Hospital Leipzig Leipzig, Germany, 04103 Department of Neurosurgery, University of Heidelberg, Medical Faculty of Mannheim Mannheim, Germany, 68167 Department of Neurosurgery, University Hospital Muenster Muenster, Germany, 48149 Department of Neurosurgery, University Hospital Munich (LMU) Munich, Germany, 81377 Department of Neurology, University Hospital Regensburg Regensburg, Germany, 93053 Less <<
NCT00295815 Glioblastoma Phase 3 Completed - -
NCT01563614 Leptomeningeal Metastasis From... More >> Malignant Melanoma Less << Phase 1 Terminated(No patients can be ... More >>recruited for this trial anymore due to other therapeutical approaches that became available.) Less << - Germany ... More >> Neurologische Universitaetsklinik Bonn Bonn, Germany, 53127 Less <<
NCT00527657 Brain Neoplasms ... More >> Melanoma Less << Phase 1 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00006024 Brain Tumor C... More >>entral Nervous System Tumor Less << Phase 1 Completed - -
NCT02765165 Solid Tumors (Phase 1) ... More >> Relapsed/Recurrent GBM (Phase 2) Less << Phase 1 Phase 2 Active, not recruiting - United States, Oklahoma ... More >> University of Oklahoma Stephenson Cancer Center Oklahoma City, Oklahoma, United States United States, Texas University of Texas/MD Anderson Cancer Center Houston, Texas, United States South Texas Accelerated Research Therapeutics (START) San Antonio, Texas, United States Spain South Texas Accelerated Research Therapeutics (START) - CIOCC Madrid, Spain South Texas Accelerated Research Therapeutics (START) FJD Madrid, Spain Less <<
NCT00480064 Acute Myeloid Leukemia Phase 3 Completed - France ... More >> Josy REIFFERS, MD MS Pessac, France, 33604 Less <<
NCT01067469 Brain Cancer ... More >>Glioblastoma Less << Phase 2 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01737346 Recurrent Glioblastoma Multifo... More >>rme Less << Phase 2 Unknown April 2014 Korea, Republic of ... More >> Ajou University Hospital Recruiting Wonchon-dong, Suwon, Korea, Republic of, 443-721 Contact: Se-Hyuk Kim, Doctor    82-31-219-5235    nsksh@ajou.ac.kr    Principal Investigator: Se-Hyuk Kim, Doctor Less <<
NCT00590837 Acute Myeloid Leukemia PHASE3 COMPLETED 2025-12-13 Services maladies du sang, can... More >>cérologie, H?pital Sud, CHU Amiens, Amiens, 80054, France|Service des maladies du sang, Centre Hospitalier Universitaire d'Angers, Angers, 49033, France|Service Hématologie, Centre Hospitalier Annecy, Annecy, 74011, France|C.H Victor Dupouy, Argenteuil, 95100, France|Service Médecine Interne, Onco-Hématologie, Maladies Infectieuses, H?pital Henri Duffaut, Centre Hospitalier Avignon, Avignon, 84000, France|Service Hématologie, Centre Hospitalier de la C?te Basque, Bayonne, 64109, France|Service Hématologie, H?pital Minjoz, Besan?on, 25030, France|Unité Hématologie, Centre Hospitalier Blois, Blois, 41016, France|Service des maladies du sang - H?pital Haut-Lévêque, Bordeaux - Pessac, 33604, France|Service Hématologie, H?pital Dr Duchenne, Boulogne-sur-Mer, 62321, France|Service Hématologie, H?pital Augustin Morvan, Brest, 29609, France|Service Hématologie et Thérapie cellulaire, Pavillon Villemin Pasteur, CHU Clermont-Ferrand, Clermont-Ferrand, 63000, France|Service Oncologie - Hématologie, H?pital Pasteur, Centre Hospitalier Colmar, Colmar, 68024, France|Service Hématologie Clinique, CHU Dijon H?pital des enfants, Dijon, 21079, France|Service Hématologie Clinique, H?pital Michallon, CHU de Grenoble, Grenoble, 38043, France|Service Onco-Hématologie 3, Institut Paoli Calmettes, Marseille, 13275, France|Service Hématologie Oncologie, CHR Metz-Thionville, Metz, 57038, France|Service Hématologie Oncologie, H?pital Lapeyronie, CHU de Montpellier, Montpellier, 34295, France|Département d'hématologie, H?pital E.Muller, Centre Hospitalier de Mulhouse, Mulhouse, 68070, France|Service Hématologie Clinique, CHU -H?tel Dieu, Nantes, 44093, France|Service Hématologie Clinique, H?pital Archet 1, Nice, 06202, France|Service Médecine B - Unité Onco-hématologique, CHU Caremeau, N?mes, 30029, France|Service Oncologie Médicale, H?pital de la Source, Orléans, 45067, France|Unité d'Hématologie, H?pital Cochin, Paris, 75679, France|Service Hématologie, CHG Saint Jean, Perpignan, 66000, France|Service Hématologie Clinique, H?pital Robert Debre, Reims, 51092, France|Service Hématologie Clinique, H?pital Pontchaillou, Rennes, 35033, France|Service d'Hématologie, Institut de Cancérologhie de la Loire, Saint Priez en Jarez, 42270, France|Département d'Hématologie et d'Oncologie, H?pital CHRU de Hautepierre, Strasbourg, 67098, France|Service Hématologie, H?pital Purpan, Toulouse, 31059, France|Service Hématologie Clinique, H?pital Bretonneau, Tours, 37044, France|Service Hématologie - Médecine Interne, H?pitaux de Brabois, Vandoeuvre-les-Nancy, 54511, France Less <<
NCT00503204 Recurrent Glioblastoma ... More >> Brain Tumor Less << Phase 1 Completed - United States, Massachusetts ... More >> Research Site Boston, Massachusetts, United States United Kingdom Research Site Sutton, United Kingdom Less <<
NCT02796261 Anaplastic Astrocytoma ... More >> Recurrent Anaplastic Astrocytoma Less << Phase 3 Recruiting August 2019 -
NCT02986178 Malignant Glioma Phase 2 Recruiting May 2023 United States, California ... More >> UCSF Neurological Surgery Recruiting San Francisco, California, United States, 94941 Contact: Nicholas Butowski, MD    415-353-2966    nicholas.butowski@ucsf.edu    Contact: Eduardo R Almaraz    415-514-5529    eduardo.rodriguez@ucsf.edu    United States, Florida Boca Raton Regional Hospital Recruiting Boca Raton, Florida, United States, 334486 Contact: Frank D Vrionis, MD,MPH,PhD    561-955-4244    fvrionis@brrh.com    Contact: Pilar Zuniga    561-955-3723    pzuniga@brrh.com    United States, Massachusetts Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: William T Curry, MD    617-724-8770    wcurry@mgh.harvard.edu    United States, North Carolina Preston Robert Tisch Brain Tumor Center at Duke University Recruiting Durham, North Carolina, United States, 27710 Contact: David Ashley, MBBS, FRACP, PhD    919-684-5301       Contact: Stevie Threatt    919-684-5301 Less <<
NCT01989052 Malignant Glioma (WHO Grade II... More >>I or IV) Less << Phase 1 Terminated(This study was term... More >>inated early due to funding issues prior to completion of phase I) Less << - United States, North Carolina ... More >> The Preston Robert Tisch Brain Tumor Center at Duke Durham, North Carolina, United States, 27710 Less <<
NCT01562197 Glioblastoma Multiforme Phase 2 Active, not recruiting December 2017 Belgium ... More >> UZ Brussel Brussel, Belgium, 1090 Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

4.28mL

0.86mL

0.43mL

21.39mL

4.28mL

2.14mL

42.79mL

8.56mL

4.28mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories